We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arrowhead Pharmaceuticals Inc | NASDAQ:ARWR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.14% | 22.12 | 21.53 | 22.46 | 22.36 | 21.72 | 22.12 | 617,126 | 01:00:00 |
1. Name and Address of Reporting Person * PERRY MICHAEL S | 2. Issuer Name and Ticker or Trading Symbol ARROWHEAD PHARMACEUTICALS, INC. [ ARWR ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/14/2020 | M | 7000 | A | $4.75 | 15000 | D | |||
Common Stock | 5/14/2020 | M | 5000 | A | $2.01 | 20000 | D | |||
Common Stock | 5/14/2020 | M | 15000 | A | $2.19 | 35000 | D | |||
Common Stock | 5/14/2020 | M | 10000 | A | $2.62 | 45000 | D | |||
Common Stock | 5/14/2020 | M | 15000 | A | $5.19 | 60000 | D | |||
Common Stock | 5/14/2020 | M | 25000 | A | $4.20 | 85000 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Common Stock (right to buy) | $4.75 | 5/14/2020 | M | 7000 | 9/21/2014 (1) | 9/21/2023 | Common Stock | 7000 | $0.00 | 70000 | D | ||||
Common Stock (right to buy) | $2.01 | 5/14/2020 | M | 5000 | 5/6/2014 (1) | 5/6/2023 | Common Stock | 5000 | $0.00 | 65000 | D | ||||
Common Stock (right to buy) | $2.19 | 5/14/2020 | M | 15000 | 3/21/2014 (1) | 3/21/2023 | Common Stock | 15000 | $0.00 | 50000 | D | ||||
Common Stock (right to buy) | $2.62 | 5/14/2020 | M | 10000 | 9/28/2013 (1) | 9/28/2022 | Common Stock | 10000 | $0.00 | 40000 | D | ||||
Common Stock (right to buy) | $5.19 | 5/14/2020 | M | 15000 | 2/16/2013 (1) | 2/16/2022 | Common Stock | 15000 | $0.00 | 25000 | D | ||||
Common Stock (right to buy) | $4.20 | 5/14/2020 | M | 25000 | 1/1/2012 (2) | 12/22/2021 | Common Stock | 25000 | $0.00 | 0 | D |
Explanation of Responses: | |
(1) | Option vested entirely on the one year anniversary of the grant date. |
(2) | Represents first vesting date. Option vested over four years from date of grant. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
PERRY MICHAEL S 177 E. COLORADO BLVD SUITE 700 PASADENA, CA 91105 | X |
Signatures | ||
/s/Michael Perry | 5/18/2020 | |
**Signature of Reporting Person | Date |
1 Year Arrowhead Pharmaceuticals Chart |
1 Month Arrowhead Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions